MillerDaniel EvaristeUnited Kingdom

Dr. Daniel Miller is a principal scientist at Evariste, an AI-enabled biotech with a discovery platform covering all of the preclinical stages of drug discovery. He studied for his PhD in cell signaling and cancer biology at the Francis Crick Institute before moving to the Institute of Cancer Research for postdoctoral research, validating novel molecular glue-like degraders in B-cell lymphoma. At Evariste, he has established a target identification platform focussed on identifying new synthetic lethal gene pairs and manages the biological assays that support Evariste’s drug discovery pipeline.